Related Experiment Videos
HLA-DM and the MHC class II antigen presentation pathway
P E Jensen1, D A Weber, W P Thayer
1The Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA. pjensen@bimcore.emory.edu
Immunologic Research
|March 31, 2000
Summary
The major histocompatibility complex (MHC) class II pathway presents peptides to CD4+ T cells. Accessory proteins, invariant chain and HLA-DM, are crucial for peptide loading and presentation.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- The major histocompatibility complex (MHC) class II pathway is essential for adaptive immunity.
- This pathway presents peptides derived from extracellular or endosomal sources to CD4+ T cells.
- Antigen-presenting cells (APCs) utilize this pathway to initiate immune responses.
Purpose of the Study:
- To elucidate the roles of accessory proteins in MHC class II antigen processing and presentation.
- To understand the mechanism of invariant chain interaction with MHC class II molecules.
- To investigate the function of HLA-DM in facilitating peptide loading and exchange.
Main Methods:
- The study focuses on the molecular mechanisms of MHC class II antigen processing.
- Key accessory proteins, invariant chain and HLA-DM, are investigated for their functions.
- The interaction between these proteins and MHC class II molecules is examined.
Main Results:
- Invariant chain binds to the peptide-binding site of newly synthesized MHC class II molecules, guiding them to the endosomal pathway.
- HLA-DM, an MHC-encoded protein, catalyzes the release of invariant chain and facilitates peptide loading onto MHC class II molecules.
- HLA-DM's activity influences the final repertoire of peptides presented to T cells.
Conclusions:
- Invariant chain and HLA-DM are critical accessory proteins in the MHC class II antigen processing pathway.
- These proteins regulate the selection and presentation of peptides, shaping the T cell response.
- Understanding this pathway is vital for developing immunotherapies and vaccines.